Gastroesophageal Reflux Treatment in Scleroderma

NCT01878526 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Reflux Disease
Systemic Sclerosis
Scleroderma

Interventions

DRUG: Alginic acid
DRUG: placebo (for domperidone)
DRUG: Domperidone
DRUG: placebo (of alginic acid)

Sponsor

Khon Kaen University